Advertisement
Home Tags Diabetes: Misc.

Tag: Diabetes: Misc.

ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes

0

Discontinuation of GLP-1 receptor agonists suggested before conception rather than between start of pregnancy and end of first trimester

Prevalence, Incidence of Diabetic Retinal Disease Increased in Recent Years

0

However, incidence rates of vision-threatening diabetic retinopathy, diabetic macular edema, and proliferative diabetic retinopathy have decreased

American Diabetes Association, June 20-23

0
By Beth Gilbert HealthDay Reporter The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than...

ADA: Ecnoglutide Yields Superior, Sustained Reduction in Body Weight

0

Sustained reduction seen in body weight versus placebo for adults aged 18 to 75 with overweight or obesity, without diabetes

Increasing Proportion of U.S. Adults Unaware They Have Hypertension

0

No change seen in proportion of adults unaware they had diabetes or high cholesterol levels

GLP-1 Receptor Agonist Exposure Linked to Neovascular AMD in Patients With Diabetes

0

More than twofold increased risk seen for nAMD development in unadjusted and adjusted models

High Transepidermal Water Loss in Diabetic Foot Ulcer Tied to Recurrence

0

High TEWL at center of recently healed diabetic foot ulcer linked to increased odds of recurrence

Lamivudine Improves Visual Acuity in Center-Involved Diabetic Macular Edema

0

Best corrected visual acuity improved 9.8 letters with lamivudine after four weeks, decreased 1.8 letters with placebo

ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death

0

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes

Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills

0
By I. Edwards HealthDay Reporter FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop...